The NEET token is in spotlight due to its price surges driven by capital rotation from major cryptocurrencies to its innovative niche platform.The NEET token is in spotlight due to its price surges driven by capital rotation from major cryptocurrencies to its innovative niche platform.

NEET’s 290.1% Price Surge On Spotlight As Analyst Eyes Huge Upside

For feedback or concerns regarding this content, please contact us at [email protected]
markett main4

The NEET coin has found itself at the center of crypto spotlight as its price continues to record significant spikes, as disclosed by market analyst AtsDaddy.

The digital asset is displaying resilience by embracing stable upside movements, with its price currently trading at $0.02946 and its trading volume reaching a high of $5,323,005, according to a revelation disclosed today by the analyst.

The Not in Employment, Education, or Training (NEET) coin is a cryptocurrency built on the Solana blockchain, whose name is a short form of Not in Education, Employment, or Training. The token aims to build a community around this social identity while offering decentralized applications for its members. The asset seeks to support young people who are neither in employment nor in education, providing them with resources to help them find their way forward.

Catalyst Behind NEET’s Momentum

Today, NEET experienced an 8.3% rise, making its value to currently trade at $0.02795, according to the latest data from CoinGecko. Its price has also been up 23.8% and 290.1% over the past week and month respectively, a surge that makes it one of the best performers in the crypto market currently. The record above shows strong investor confidence in the asset as increasing numbers of buyers continue entering the NEET market, engaging in heightened buying activities.

The broader cryptocurrency remains in a turbulent phase, with drastic price declines testing investors’ patience and strategies. Today, prices of major crypto assets such as Bitcoin and Ethereum stabilized at $72,533 and $2,126 respectively after substantial dips (as per data from CoinMarket). Their inability to recover from the highs of $90,000 and $3,000 noted in early January has been further worsened by geopolitical and macroeconomic factors, including the ongoing tension in the Middle East due to coordinated Israeli and US strikes against Iran.

Amid the continuing crypto market instability, the NEET token has emerged as a preferred buying opportunity for traders seeking to take advantage of its market capability. Its remarkable price rise indicates capital rotation from major crypto assets to specialized (niche) tokens like NEET and several others. The 156.6% and 290.1% surges registered over the past two weeks and month in the NEET market are an outcome of this rotation, combined with a coordinated crypto community engagement in its platform.

NEETUSDThe current price of NEET is $0.02767.

NEET Prints Bullish Pattern, More Surges To Come

Amidst this bullish movement, the analyst believes that NEET is likely to witness greater climbs due to excitement in its new decentralized market.

Technical analysis shows that the asset is building an ascending triangle pattern. And together with the improvement of market sentiment, technical projection signals that NEET could further surge by more than 40% from its current price in the coming days. 

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09